Essential medicines and health products

WHO/UNICEF Technical Briefing Seminar
on Essential Medicines Policies,
31 October - 4 November 2011,
World Health Organization Headquarters, Geneva.
M-505, M Building


MONDAY, 31 OCTOBER 2011

Facilitation: Dr Richard Laing, EMP/MIE

08:30-09:00
Registration (M-505, M-Building, WHO/Headquarters)

Introduction

09:00-09:30
Welcome
Dr Carissa Etienne, ADG/HSS and Acting Director EMP
Objectives of the seminar
Richard Laing EMP/MIE

09:30-10:15
Introduction of participants: gallery of experts
Mrs Helen Tata, EMP/MPC & MAR and Ms Caroline Mendy, EMP/QSM


10:15-10:45 Tea/Coffee break


10:45-11:00
Seminar overview and administration
Mrs Anita Korinsek-Porta, EMP/MIE; Ms Francine Neyroud, EMP/MPC;
Ms Teija Katajainen EMP/OOD

11:00-11:30
EMP role and responsibilities in implementing the WHO Medicines Strategy
Richard Laing EMP/MIE and Dr Jean-Marie Trapsida, RA/AFRO

11:30-12:30
Information resources
Mr Claude Da Re, EMP/MIE and Mrs Kath Hurst, EMP/MIE


12:30-14:00 Lunch



Facilitation: Dr Clive Ondari, EMP/MAR


National Medicines Policies

14:00-14:45
National Medicines Policies Process, World Medicines Situation and Access to Medicines Index
Dr Richard Laing, EMP/MIE

14:45-15:45
Pharmaceutical Sector Profiles of Countries
Dr Gilles Forte, EMP/MPC and others


15:45-16:00 Tea/Coffee break



Selection of Essential Medicines

16:00-17:00
Update on WHO model list of essential medicines and paediatric medicines
Dr Richard Laing, EMP/MIE


Share